Schedule 13G ownership disclosure
CONDUIT PHARMACEUTICALS INC
Common Stock, $0.0001 par value · CUSIP: 20678X106
Event date: 2025-01-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nirland Limited
Shares: 15,350,000.00 · Class: 9.979%
- Stockton Limited
Shares: 15,350,000.00 · Class: 9.979%
- The Rowland Master Trust
Shares: 15,350,000.00 · Class: 9.979%
- Dovet Limited
Shares: 15,350,000.00 · Class: 9.979%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-005052
- Form type
- SCHEDULE 13G
- Filer
- CDT Equity Inc.
- CIK
- CIK 1896212
- Filed
- Jan 21, 2025
- Reporting period
- Jan 13, 2025
- Description
- Schedule 13G beneficial ownership